Exploring the feasibility of an exercise programme including aerobic and resistance training in people with limited cutaneous systemic sclerosis

Alexandros Mitropoulos, Anil Gumber, Helen Crank, Mohammed Akil, Markos Klonizakis, Alexandros Mitropoulos, Anil Gumber, Helen Crank, Mohammed Akil, Markos Klonizakis

Abstract

Objectives: It is suggested that exercise can improve the vascular function and quality of life (QoL) in people with systemic sclerosis (SSc), potentially offering clinical benefits to this population. Yet the feasibility of such an intervention remains untested. Therefore, the purpose of this study is to examine the feasibility of a combined exercise protocol (aerobic and resistance training) in people with limited cutaneous SSc (lcSSc).

Methods: Thirty-two lcSSc patients (66.5 ± 12 years old) were randomly allocated in two groups (exercise and control group). The exercise group underwent a 12-week exercise programme, twice per week. All patients performed the baseline, three- and six-month follow-up measurements where functional ability, body composition and QoL were assessed. Participants' experiences were explored through interviews.

Results: Compliance was 92.6% with no dropouts. The individuals' confidence to participate in the study's exercise protocol for twice per week was 95%. The average value for the physical activity enjoyment scale was 103 ± 10 out of 119 (highest score). The mean values for the intention to engage in exercise twice per week were 6.4 ± 1 (likely) out of 7 (very likely). QoL for the exercise group showed to have a better life satisfaction, less anxiety and Raynaud's phenomenon-accompanied pain.

Conclusions: Our results suggest that a combined exercise protocol was feasible for people with lcSSc, with no adverse events, resulting in high adherence and low attrition rates, high enjoyment levels and intentions for future engagement to this exercise. Thus, the specific protocol is a safe adjunct therapy for people with lcSSc.

Trial registration: ClinicalTrials.gov (NCT number): NCT03058887, February 23, 2017, https://ichgcp.net/clinical-trials-registry/NCT03058887?term=NCT03058887&rank=1Key Points• High-intensity interval training in combination with resistance training constitutes a feasible exercise protocol for people with lcSSc.• Overall, the exercise programme demonstrated high adherence and enjoyment levels and low attrition rates.• The exercise protocol was proved to be safe with no adverse events for people with lcSSc.

Keywords: Digital ischemia; High-intensity interval training; Quality of life; Resistance training.

Figures

Fig. 1
Fig. 1
Flow of participants through the trial

References

    1. Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272. doi: 10.3389/fimmu.2015.00272.
    1. Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol. 2018;37:2103–2111. doi: 10.1007/s10067-018-4182-3.
    1. Cohen ND, Dunstan DW, Robinson C, Vulikh E, Zimmet PZ, Shaw JE. Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. Diabetes Res Clin Pract. 2008;79:405–411. doi: 10.1016/j.diabres.2007.09.020.
    1. Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Arthritis Care Res. 2011;63:142–149. doi: 10.1002/acr.20336.
    1. Deuschle K, Weinert K, Becker MO, Backhaus M, Huscher D, Riemekasten G. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Clin Exp Rheumatol. 2011;29:S53–S59.
    1. Mouthon L, Carpentier PH, Lok C, Clerson P, Gressin V, Hachulla E, Bérezné A, Diot E, Khau van Kien A, Jego P, Agard C, Duval-Modeste AB, Sparsa A, Puzenat E, Richard MA, ECLIPSE Study Investigators Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J Rheumatol. 2014;41:1317–1323. doi: 10.3899/jrheum.130900.
    1. Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford) 2010;49:1739–1746. doi: 10.1093/rheumatology/keq145.
    1. Ingraham KM. Morbidity of digital tip ulcerations in scleroderma. Arthrit Rheumatol. 2006;54:P578.
    1. Mitropoulos A, Gumber A, Crank H, Akil M, Klonizakis M. The effects of upper and lower limb exercise on the microvascular reactivity in systemic sclerosis patients. Arthritis Res Ther. 2018;20:112. doi: 10.1186/s13075-018-1605-0.
    1. Dias I, Farinatti P, De Souza MG, Manhanini DP, Balthazar E, Dantas DL, et al. Effects of resistance training on obese adolescents. Med Sci Sports Exerc. 2015;47:2636–2644. doi: 10.1249/MSS.0000000000000705.
    1. Maiorana AJ, O’Driscoll JG, Dembo L, Goodman C, Taylor RR, Green DJ. Effect of combined aerobic and resistance exercise training of functional capacity, body composition and vascular function. J Am Coll Cardiol. 2001;38:860–866. doi: 10.1016/S0735-1097(01)01439-5.
    1. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen VZ, Nightingale P, Sandoo A, Dimitroulas T, et al. Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:748–751. doi: 10.1136/annrheumdis-2013-203291.
    1. Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–2747. doi: 10.1002/art.38098.
    1. Mitropoulos A, Gumber A, Crank H, Akil M, Klonizakis M. Investigating the effectiveness and feasibility of exercise on microvascular reactivity and quality of life in systemic sclerosis patients: study protocol for a feasibility study. Trials. 2018;19:647. doi: 10.1186/s13063-018-2980-1.
    1. Mitropoulos A (2018) The effects of exercise on vascular physiology in systemic sclerosis patients. Thesis, Sheffield Hallam University. . Accessed 18 Sept 2018
    1. Borg GA. Perceived exertion: a note on “history” and methods. Med Sci Sports. 1973;5:90–93.
    1. Wasilewski R, Ubara EO, Klonizakis M. Assessing the effects of a short-term green tea intervention in skin microvascular function and oxygen tension in older and younger adults. Microvasc Res. 2016;107:65–71. doi: 10.1016/j.mvr.2016.05.001.
    1. Klonizakis M, Tew GA, Gumber A, Crank H, King B, Middleton G, Michaels JA. Supervised exercise training as an adjunct therapy for venous leg ulcers: a randomised controlled feasibility trial. Br J Dermatol. 2018;178:1072–1082. doi: 10.1111/bjd.16089.
    1. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–1108. doi: 10.1097/00005650-199711000-00002.
    1. Jung ME, Bourne JE, Little JP. Where does HIT fit? An examination of the affective response to high-intensity intervals in comparison to continuous moderate- and continuous vigorous-intensity exercise in the exercise intensity-affect continuum. PLoS One. 2014;9:e114541. doi: 10.1371/journal.pone.0114541.
    1. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117. doi: 10.1186/1471-2288-13-117.
    1. Pope C, Ziebland S, Mays N. Qualitative research in health care. BMJ. 2000;320:114–116. doi: 10.1136/bmj.320.7227.114.
    1. Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheff) 2016;12:130–138. doi: 10.1183/20734735.006916.
    1. Ozalevli S, Karaali HK, Ilgin D, Ucan ES. Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2010;5:31–37. doi: 10.1186/2049-6958-5-1-31.
    1. Rammaert B, Leroy S, Cavestri B, Wallaert B, Grosbois J. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis. Rev Mal Respir. 2011;28:e52–e57. doi: 10.1016/j.rmr.2011.06.006.
    1. Parfitt G, Hughes S. The exercise intensity-affect relationship: evidence and implications for exercise behavior. J Exerc Sci Fit. 2009;7:S34–S41. doi: 10.1016/S1728-869X(09)60021-6.
    1. Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol. 2007;34:2423–2430.
    1. Steen KSS, Lems WF, Visman IM, Heierman M, Dijkmans BAC, Twisk JWR, Boers M, Nurmohamed MT. High incidence of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68:1509–1510. doi: 10.1136/ard.2008.105023.
    1. Tiev KP, Diot E, Clerson P, Dupuis-Siméon F, Hachulla E, Hatron P, Constans J, Cirstéa D, Farge-Bancel D, Carpentier PH. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie) J Rheumatol. 2009;36:1470–1476. doi: 10.3899/jrheum.081044.
    1. Ennis H, Vail A, Wragg E, Taylor A, Moore T, Murray A, Muir L, Griffiths CE, Herrick AL. A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact. Scand J Rheumatol. 2013;42:483–486. doi: 10.3109/03009742.2013.780095.
    1. Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2008;67:120–123. doi: 10.1136/ard.2007.072686.
    1. Zhou AY, Muir L, Harris J, Herrick AL. The impact of magnetic resonance imaging in early diagnosis of hand osteomyelitis in patients with systemic sclerosis. Clin Exp Rheumatol. 2014;32:S–232.
    1. Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O, Foeldvari I, Kuwana M, Matucci-Cerinic M, Mayes M, Medsger T Jr, Merkel PA, Pope JE, Seibold JR, Steen V, Stevens W, Denton CP. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2:11–18. doi: 10.5301/jsrd.5000231.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅